The Horizons Tracker

FEBRUARY 22, 2022

That we’re still largely waiting for such an immersive world to take hold, despite much-hyped initiatives, such as Second Life, perhaps underlines the difficulties the technology has had in keeping pace with such a vision. Digital twins. It’s a market that is already worth $3.1

Stephenson 84

Stephenson Wireless Christensen Automotive 84

The Horizons Tracker

MAY 2, 2023

Make sure for your organization, for your hiring and your development programs, that the ‘elitist criteria’ of your potential new hires do not become a determining factor on who’s successful or not. That’s the key takeaway of this study,” the researchers explain.

Class 105

Class CEO Education Engineering 105

N2Growth Blog

FEBRUARY 4, 2015

A move toward the Advantage Strategy Paradigm begins with the adoption and commitment to a set of principles that guides all executives in the decisions and actions they take related to developing, planning, and executing strategy. How many more times do people have to hear it before it actually becomes a priority? That is the good news.

Process 150

Process Agility Competitive Advantage Strategy 150

Marshall Goldsmith

FEBRUARY 8, 2018

Jim Kim (President of the World Bank), Peter Drucker (founder of modern management), Paul Hersey (noted author, teacher, and personal mentor of mine), and Warren Bennis (one of the world’s greatest leadership thinkers of his time). Authority on new technology and communication. Has been recognized as the World’s #1 Leadership Thinker.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Harvard Business Review

MARCH 11, 2018

That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. “Our company appreciates the progress we have seen under Prime Minister Abe’s leadership.” Older people need more medicine.

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Content 8

Tanveer Naseer

MARCH 10, 2015

For example, they might say, “We’re a bank,” or “We make office furniture,” or “We’re in the pharmaceutical business.” In other words, Larry Page sees Google as a broad portfolio of science, technology, and Internet-related resources that can be leveraged into almost any meaningful new venture. This is quite understandable.

How To 100

How To Retail Core Competence Innovation 100

Strategy Driven

JULY 13, 2011

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). As with the other measures, what is important varies by industry.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. Are You Using Dialects To Develop Your Employees’ Skills?

Bureaucracy 203

Bureaucracy Compliance Learning-by-Doing Engineering 203

Harvard Business Review

JUNE 16, 2016

Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. At the same time, the marketplace has become so fiercely competitive—and investors so demanding—that few are willing to take a flyer on an unproven technology. Killing Ideas Faster.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. In addition, many top pharma customers (payers, etc.)

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

SEPTEMBER 4, 2015

However, CEOs often don’t have the career background and education that would equip them to personally lead the process of new product development. We found that, for pharmaceutical industry CEOs, there is a statistically significant relationship between a CEO’s specialist background and the firm’s performance.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. That, in brief, is the concept of a leadership circle. In short, today’s existing leadership structure, expertise and purpose are designed to address today’s challenges — not tomorrow’s.

Leadership 10

Leadership Diversity Committee Long-term 10

Harvard Business Review

MARCH 8, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. In a world with severe healthcare resource constraints, mobile digital technology can be a major " force multiplier." There are now more than 5.3

Wireless 15

Wireless Health Care Pharmaceuticals Business Model 15

Harvard Business Review

APRIL 7, 2015

There are new types of insurance companies such as Oscar ; novel provider organizations such as OneMedical , IoraHealth , and ChenMed ; and new health information technology companies such as Castlight , Vital , and WellFrame that aim to use technology to improve care and value. People leadership.

Execution 8

Execution Skills Health Care Porter 8

Harvard Business Review

DECEMBER 27, 2016

Healthcare has become extraordinarily complex — the balance of quality against cost, and of technology against humanity, are placing ever-increasing demands on clinicians. Doctors were once viewed as ill-prepared for leadership roles because their selection and training led them to become “heroic lone healers.”

Management 15

Management 360-Degree Feedback Mayo Training 15

Strategy Driven

MARCH 18, 2011

In addition, we believe that your starting point for strategy development is what you are already great at, rather than studying the industry and market for opportunities. Is it more important to consider capabilities when you develop a strategy now than it was, say, five years ago? SD : Why now? What do most companies do instead?

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

JUNE 22, 2016

But all assets are not created equal, especially as the technological landscape changes. Even when these firms rely on physical assets, like cars for Uber, they own the technology, not the physical asset. Digital native upstarts are gutting traditional industries one at a time, leveraging scalable technology and participative networks.

Intangible Assets 10

Intangible Assets Business Model How To Intellectual Capital 10

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Arbuckle Professorship at Harvard Business School, where she specializes in strategy, innovation, and leadership. Rosabeth Moss Kanter is the Ernest L.

Health Care 15

Health Care Innovation Pharmaceuticals Consensus 15

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

FEBRUARY 2, 2015

This is the kind of technology—and the type of firm—that will make renewable energy more efficient and more cost-effective. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients. .”

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

OCTOBER 29, 2012

The nay-sayers, on the other hand, can cite the passionately defended view of the pharmaceutical industry that the cost of discovering innovative disease-curing molecules has been rising crazily — the basis for perennial campaigns for stronger intellectual property rights to safeguard pharma investments. But it's not stopping there.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

MARCH 16, 2015

Enrique Santacana of ABB North America, a power and automation-technology firm, voiced his concern this way: “An overarching issue was the exposure we had as a company,” Santacana explained, “For example, how information was being used or may be used in a way that was not conducive to good business practices. .”

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

MAY 28, 2013

In one of the most comprehensive global surveys of corporate directors to date, we found that they were very worried about developing and enacting strategic plans that will enable their organizations to succeed. Not innovation, risk management, technology, debt, or the regulatory environment. Not competitive threats. Not rising costs.

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. It seems to me that this emphasis on authenticity is an important counterbalance to earlier assumptions that people gained leadership powers by dint of titles or positions in hierarchies.

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8

Harvard Business Review

OCTOBER 23, 2017

At EY, where some of us work, we have developed a tool for social media analytics called SMAART that is able to understand sentiment within consumer and influencer groups. Along these lines, California startup LEDR Technologies is pioneering techniques to predict team performance. Build a Dashboard.

Company 8

Company Management Metrics Tools 8

Harvard Business Review

SEPTEMBER 29, 2011

They are not interested in hearing about the technological, regulatory, and societal developments that will determine the long-term, strategic positioning of this company.". Correspondingly, as a small group of firms have done, companies should stop issuing guidance for short-term earnings to the investment community.

Long-term 12

Long-term CEO Short-term Asset Management 12

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. Those factors do play important roles, but the most important thing driving America’s success has been its unparalleled scientific leadership. vincent tsui FOR HBR.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

JANUARY 26, 2011

Companies included in the ETF include major airlines, pharmaceuticals, industrials, and technology. We came back from China excited about the potential contribution this country can make to a sustainable economy and society for itself and the leadership it can provide for the rest of the world. Stay tuned.

Long-term 14

Long-term Sample Report Pharmaceuticals 14

Harvard Business Review

MARCH 9, 2015

Advances in digital technology and their use in organizations carry huge promise to empower people at all levels. For example, a study of a multinational pharmaceutical company revealed that leaders in its U.S. Leadership & Managing people Technology Managing yourself'

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

OCTOBER 22, 2013

Develop Creative Discontent. You may ask, what are some risky investments that stand a high chance of failure but, if successful, enable larger technological leaps that promise earthshaking impact? Three major factors drive convergence: technology, competition, and the customer. Let’s say you’re in the energy sector.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

MAY 10, 2013

In the early stages, incubation and launch, historically venture capitalists and angels (in addition to the "friends, families and fools" beloved of the entrepreneurship literature) have provided seed funds for organizations to develop an idea. The venture capital industry has now become fairly large and robust.

Venture Capitalist 8

Venture Capitalist Restructuring Competitive Advantage Short-term 8

Harvard Business Review

OCTOBER 27, 2014

I studied large-scale change and innovation efforts in 56 randomly selected companies in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Change management Execution Leadership' My research found that the majority of the efforts failed.

Middle Management 13

Middle Management Six Sigma Taylorism Taylor 13

Harvard Business Review

OCTOBER 11, 2013

Celine Schillinger sought to change the leadership landscape of Sanofi, a major pharmaceutical company. Today, she’s the Head of Stakeholder Engagement for their in-development Dengue Fever vaccine — one of Sanofi’s largest business initiatives. Capturing the Innovation Mind-Set at Bally Technologies. Innovation'

Innovation 11

Innovation Christensen Decisionmaking CTO 11

Harvard Business Review

NOVEMBER 7, 2012

Over the last few years, its big new product lines — including a healthy Veg Pot and its This Water line — have both come from ideas conceived and developed by mid-level employees. Some pharmaceutical scientists will spend an entire career working on drug development without a single one of their products reaching the market.

Company 8

Company Stage-Gate Innovation Bureaucracy 8